Bisphosphonate drug holidays: we reap what we sow

Osteoporos Int. 2016 Mar;27(3):849-852. doi: 10.1007/s00198-015-3453-y. Epub 2015 Dec 14.

Authors

S L Silverman¹, J D Adachi², E Dennison³; And the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

Affiliations

¹ David Geffen School of Medicine, University of California, Los Angeles; Division of Rheumatology, Cedars-Sinai Medical Center; and OMC Clinical Research Center, 8641 Wilshire Blvd, suite 301, Beverly Hills, CA, 90211, USA. stuarts@bhillsra.com.
² St Joseph's Healthcare, McMaster University, Hamilton, ON, Canada.
³ MRC Life course Epidemiology Unit Southampton University and Victoria University of Wellington, Wellington, New Zealand.

PMID: 26667246
DOI: 10.1007/s00198-015-3453-y

No abstract available

Publication types

Editorial

MeSH terms

Bone Density Conservation Agents / administration & dosage*
Bone Density Conservation Agents / adverse effects
Diphosphonates / administration & dosage*
Diphosphonates / adverse effects
Drug Administration Schedule
Humans
Osteoporosis / drug therapy*
Osteoporotic Fractures / prevention & control

Substances

Bone Density Conservation Agents
Diphosphonates

Grants and funding